These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunofluorescence studies in dermatology]. Scherer R Med Klin; 1979 Feb; 74(5):132-43. PubMed ID: 368548 [No Abstract] [Full Text] [Related]
4. [The application and value of immunofluorescence procedures in dermatology (author's transl)]. Holubar K Wien Klin Wochenschr; 1974 Jun; 86(12):325-30. PubMed ID: 4599929 [No Abstract] [Full Text] [Related]
5. [Advances in the treatment of dermatoses in autoimmunization]. Miedziński F Pol Tyg Lek; 1971 Sep; 26(39):1489-91. PubMed ID: 4940117 [No Abstract] [Full Text] [Related]
6. [Autoagression and immunosuppression in dermatology. II. Autoagression dermatoses and their detection]. Novotný F Cesk Dermatol; 1973 Jan; 48(1):37-42. PubMed ID: 4569063 [No Abstract] [Full Text] [Related]
7. [DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases]. Kerl H; Sandhofer M; Klein G; Altmann H Hautarzt; 1975 Jan; 26(1):30-4. PubMed ID: 1090563 [No Abstract] [Full Text] [Related]
8. [The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus]. Thivolet J; Beyvin AJ; Le Mot J Lyon Med; 1972 Feb; 227(3):241-5. PubMed ID: 5037158 [No Abstract] [Full Text] [Related]
9. [Immunofluorescent method in dermatology (review of the literature)]. Dobzhanskiĭ SI; Tabakova LS Vestn Dermatol Venerol; 1974 Aug; 0(8):13-8. PubMed ID: 4611090 [No Abstract] [Full Text] [Related]
11. [The mechanism of autoimmune cutaneous diseases]. Jablonska S; Chorzelski T Ann Dermatol Syphiligr (Paris); 1971; 98(4):377-92. PubMed ID: 4945246 [No Abstract] [Full Text] [Related]
12. [Elution and study of the specificity of antibodies fixed in vivo at the level of the skin in pemphigus, bullous pemphigoid and lupus erythematosus]. Thivolet J; Beyvin AJ; Le Mot J Ann Dermatol Syphiligr (Paris); 1972; 99(3):290. PubMed ID: 4654113 [No Abstract] [Full Text] [Related]
13. Cutaneous immunofluorescence in systemic disease. Engelman MW; Hodge SJ; Owen LG J Ky Med Assoc; 1977 Jun; 75(6):273-8. PubMed ID: 326999 [No Abstract] [Full Text] [Related]
14. [1st results of immunofluorescence examinations of skin lesions treated with pemphigus or systemic erythematosus serums]. Cutrone P G Ital Dermatol Minerva Dermatol; 1971 Aug; 46(8):341-5. PubMed ID: 5170975 [No Abstract] [Full Text] [Related]
15. Editorial: Skin disease and immunofluorescence. Med J Aust; 1973 Sep; 2(12):571-2. PubMed ID: 4592290 [No Abstract] [Full Text] [Related]
16. Pemphigus and other diseases. Results of indirect intercellular immunofluorescence. Anderson HJ; Newcomer VD; Landau JW; Rosenthal LH Arch Dermatol; 1970 May; 101(5):538-46. PubMed ID: 4910380 [No Abstract] [Full Text] [Related]
17. [Progresses in the field of immunodermatology]. Jabłoónska S; Chorzelski T Z Hautkr; 1974 Sep; 49(17):721-9. PubMed ID: 4373951 [No Abstract] [Full Text] [Related]
18. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions. Burnham TK; Neblett TR; Fine G Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010 [No Abstract] [Full Text] [Related]
19. [Lupus-pemphigus]. Gimeno Carpio E; Sńchez Carazo JL; Vilata Corell JJ; Aliaga Boniche A Med Cutan Ibero Lat Am; 1986; 14(6):401-5. PubMed ID: 3550315 [TBL] [Abstract][Full Text] [Related]
20. [Significance of immunofluorescence in dermatology]. Holubar K Z Haut Geschlechtskr; 1970 Feb; 45(3):113-20. PubMed ID: 4911829 [No Abstract] [Full Text] [Related] [Next] [New Search]